Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 1:53 pm Purchase |
2024-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Samlyn Capital, LLC | 6,667,105 9.800% |
403,347 (+6.44%) |
Filing History |
| 2025-02-13 4:30 pm Purchase |
2024-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
MILLER RICHARD A MD | 5,220,368 7.700% |
1,536,358 (+41.70%) |
Filing History |
| 2024-08-01 9:18 pm Sale |
2024-08-01 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Samlyn Capital, LLC | 6,263,758 9.990% |
-4,226 (-0.07%) |
Filing History |
| 2024-05-13 4:52 pm Purchase |
2024-05-01 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Samlyn Capital, LLC | 6,267,984 9.990% |
3,771,725 (+151.10%) |
Filing History |
| 2024-05-09 5:29 pm Purchase |
2024-05-02 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Point72 Asset Management, L.P. | 17,050,384 9.900% |
17,050,384 (New Position) |
Filing History |
| 2024-05-08 7:55 pm Unchanged |
2024-05-06 | 13D | Corvus Pharmaceuticals, Inc. CRVS |
ORBIMED ADVISORS LLC | 6,943,654 11.100% |
0 (Unchanged) |
Filing History |
| 2024-02-14 1:31 pm Purchase |
2023-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Samlyn Capital, LLC | 2,496,259 5.100% |
2,496,259 (New Position) |
Filing History |
| 2024-02-13 6:27 pm Purchase |
2023-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
MILLER RICHARD A MD | 3,684,010 7.190% |
578,889 (+18.64%) |
Filing History |
| 2023-02-14 4:00 pm Sale |
2022-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
TANG CAPITAL PARTNERS LP | 0 0.000% |
-3,101,709 (Position Closed) |
Filing History |
| 2023-02-13 12:01 pm Purchase |
2022-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
CHI Advisors LLC | 2,384,402 5.120% |
2,384,402 (New Position) |
Filing History |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
MILLER RICHARD A MD | 3,105,121 6.450% |
497,973 (+19.10%) |
Filing History |
| 2023-01-30 4:17 pm Sale |
2022-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Integrated Core Strategies (US) LLC | 1,899,516 4.100% |
-1,020,543 (-34.95%) |
Filing History |
| 2022-02-14 4:15 pm Sale |
2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Venrock Healthcare Capital Partners II, L.P. | 250,000 0.500% |
-3,177,461 (-92.71%) |
Filing History |
| 2022-02-14 4:00 pm Purchase |
2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
TANG CAPITAL PARTNERS LP | 3,101,709 6.700% |
3,101,709 (New Position) |
Filing History |
| 2022-02-11 7:30 pm Sale |
2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
BIOTECHNOLOGY VALUE FUND L P | 1,370,947 3.000% |
-1,527,850 (-52.71%) |
Filing History |
| 2022-02-11 5:55 pm Purchase |
2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
MILLER RICHARD A MD | 2,607,148 5.450% |
427,589 (+19.62%) |
Filing History |
| 2022-01-18 4:55 pm Purchase |
2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Integrated Core Strategies (US) LLC | 2,920,059 6.300% |
403,531 (+16.04%) |
Filing History |
| 2021-12-06 4:44 pm Purchase |
2021-12-01 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Integrated Core Strategies (US) LLC | 2,516,528 5.400% |
487,927 (+24.05%) |
Filing History |
| 2021-11-03 3:03 pm Unchanged |
2021-11-02 | 13D | Corvus Pharmaceuticals, Inc. CRVS |
ORBIMED ADVISORS LLC | 6,943,654 14.900% |
0 (Unchanged) |
Filing History |
| 2021-10-22 4:36 pm Purchase |
2021-10-12 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Integrated Core Strategies (US) LLC | 2,028,601 4.800% |
2,028,601 (New Position) |
Filing History |